EUVIMEDEUVIMED entdecken
Multizentrische Studie

Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma

Filippo Tommaso Gallina iD, Fabiana Letizia Cecere, Riccardo Tajè, Luca Bertolaccini iD, Monica Casiraghi iD, Lorenzo Spaggiari iD, Giorgio Cannone, Alberto Busetto iD, Federico Rea, Nicola Martucci, Giuseppe De Luca, Edoardo Mercadante und 10 weitere

European Journal of Cardio-Thoracic Surgery · 04.11.2024 · 66 (5)

DOI: 10.1093/ejcts/ezae406 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 12.11.2024. Verfasst von Filippo Tommaso Gallina und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Adenocarcinoma of Lung, Lung Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES This study aimed to evaluate the predictive and prognostic factors in clinical stage I, anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinoma following radical surgery. Additionally, it sought to compare these factors with an external cohort of ALK wild-type patients. METHODS A multicentric, retrospective, case–control analysis was conducted on patients with clinical T1-2 N0 ALK-rearranged lung adenocarcinoma who underwent anatomical resection and radical lymphadenectomy. Data were collected from 5 high-volume oncological centres. An external cohort of ALK wild-type patients was also analysed for comparison. Survival analyses were performed using the Kaplan–Meier method, and multivariable Cox regression analysis was used to identify prognostic factors. RESULTS From January 2016 to December 2022, 63 patients with ALK-rearranged lung adenocarcinoma were included. High-grade tumours (G3) significantly associated with upstaging (odds ratio = 3.904, P = 0.04). Disease-free survival (DFS) and overall survival were significantly improved in upstaged patients receiving adjuvant treatment [hazard ratio (HR) = 0.18, P = 0.0042; HR = 0.24, P = 0.0004, respectively]. The solid or micropapillary histological subtypes were independently associated with worse DFS (HR = 3.41, P = 0.022). Comparison with 435 ALK wild-type patients showed worse DFS in the ALK-rearranged group (HR = 2.09, P = 0.0003). ALK-rearranged patients had higher rates of nodal upstaging, systemic and brain recurrences. CONCLUSIONS Clinical T1-2 N0 ALK-rearranged lung adenocarcinoma is an aggressive disease with a specific tropism for lymph nodes and the brain. High-grade tumours are predictive of nodal upstaging. Adjuvant treatment significantly improves DFS and overall survival in upstaged patients, highlighting the need for personalized preoperative staging and post-surgical management in this cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anaplastic Lymphoma KinaseAdenocarcinoma of LungLung NeoplasmsNeoplasm StagingHumansMaleFemaleMiddle AgedRetrospective StudiesPrognosisAgedCase-Control StudiesAdultGene Rearrangement

Stichwörter der Autor:innen

Anaplastic lymphoma kinase-rearrangedEarly stageLung adenocarcinomaLung cancerNon-small cell lung cancer

Substanzen

Anaplastic Lymphoma KinaseALK protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Department of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Thoracic Surgery and Lung Transplantation Unit, University-Hospital of Padova, Padova, Italy.
  • Thoracic Surgery Unit, Istituto Nazionale Tumori, "Fondazione G. Pascale"-IRCCS, Napoli, Italy.

ORCID-Profile: Filippo Tommaso Gallina, Luca Bertolaccini, Monica Casiraghi, Lorenzo Spaggiari, Alberto Busetto, Luca Voltolini, Federico Cappuzzo

Zitieren

APA

Gallina, F. T., Cecere, F. L., Tajè, R., Bertolaccini, L., Casiraghi, M., Spaggiari, L., Cannone, G., Busetto, A., Rea, F., Martucci, N., De Luca, G., Mercadante, E., Mazzoni, F., Bongiolatti, S., Voltolini, L., Melis, E., Sperduti, I., Cappuzzo, F., Rayes, R., …, & Spicer, J. (2024). Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma. European Journal of Cardio-Thoracic Surgery, 66(5). https://doi.org/10.1093/ejcts/ezae406

Vancouver

Gallina FT, Cecere FL, Tajè R, Bertolaccini L, Casiraghi M, Spaggiari L, et al. Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma. European Journal of Cardio-Thoracic Surgery. 2024;66(5). doi:10.1093/ejcts/ezae406

BibTeX
@article{Gallina2024,
  author = {Gallina, Filippo Tommaso and Cecere, Fabiana Letizia and Tajè, Riccardo and Bertolaccini, Luca and Casiraghi, Monica and Spaggiari, Lorenzo and Cannone, Giorgio and Busetto, Alberto and Rea, Federico and Martucci, Nicola and De Luca, Giuseppe and Mercadante, Edoardo and Mazzoni, Francesca and Bongiolatti, Stefano and Voltolini, Luca and Melis, Enrico and Sperduti, Isabella and Cappuzzo, Federico and Rayes, Roni and Ferri, Lorenzo and Facciolo, Francesco and Spicer, Jonathan},
  title = {Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  volume = {66},
  number = {5},
  doi = {10.1093/ejcts/ezae406}
}
Kostenlos starten →